Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) shot up 0% during mid-day trading on Monday . The stock traded as high as $10.81 and last traded at $10.37. 20,250 shares traded hands during trading, an increase of 125% from the average session volume of 9,019 shares. The stock had previously closed at $10.3690.
Santen Pharmaceutical Stock Up 0.0%
The business’s 50 day moving average is $10.12 and its 200-day moving average is $10.75.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Featured Stories
- Five stocks we like better than Santen Pharmaceutical
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- The Last Gold Bull Market
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
